Who owns GT BIOPHARMA INC COM NEW?
- Ticker: GTBP
- CUSIP Number: 36254l308
Tip: Access positions for across all investors
Analyze quarterly positions in Gt Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Gt Biopharma stock
Who bought or sold GT BIOPHARMA INC COM NEW this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| DRW Holdings | 142k | $84k | 100% | Sep 2025 |
|
| Bank Of Montreal | 93k | $331k | 100% | Jun 2025 |
|
| Citadel Advisors | 40k | $24k | 100% | Sep 2025 |
|
| Geode Capital Management | 24k | $14k | 1% | Sep 2025 |
|
| Two Sigma Securities | 17k | $10k | 100% | Sep 2025 |
|
| Vanguard Group | 11k | $6.2k | 0% | Sep 2025 |
|
| Wells Fargo & Company | 10k | $5.9k | 0% | Sep 2025 |
|
| BlackRock | 9.7k | $5.7k | 0% | Sep 2025 |
|
| Advisor Group Holdings | 5.1k | $3.0k | -56% | Sep 2025 |
|
| Morgan Stanley | 4.0k | $14k | 100% | Jun 2025 |
|
| Newbridge Financial Services Group | 3.8k | $2.2k | 36% | Sep 2025 |
|
| UBS Group | 2.6k | $1.5k | -55% | Sep 2025 |
|
| Tower Research Capital | 1.7k | $999.055200 | 279% | Sep 2025 |
|
| Hartland & Co | 865.00 | $508.014500 | 0% | Sep 2025 |
|
| Jones Financial Companies, L.L | 300.00 | $230.010000 | 0% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 16.00 | $9.000000 | 0% | Sep 2025 |
|
| Blue Bell Private Wealth Management | 10.00 | $6.000000 | 0% | Sep 2025 |
|
| SBI Securities | 5.00 | $3.000000 | -17% | Sep 2025 |
|
| Hanson McClain Advisors | 1.00 | $1.000000 | 0% | Sep 2025 |
|
| Jpmorgan Chase & Co | 1.00 | $1.000000 | 0% | Sep 2025 |
|
Who sold out of Gt Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Renaissance Technologies | Jun 2025 | 26k | $94k |
| Mount Yale Investment Advisors | Jun 2025 | 46.00 | $165.002000 |
| Front Row Advisors | Jun 2025 | 1.00 | $4.000000 |